NDC Package 60215-411-30 Fludeoxyglucose F18

Fludeoxyglucose F18 Injection Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information
Other Packages
Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

60215-411-30

Package Description:

27 mL in 1 VIAL, GLASS

Product Code:

60215-411

Proprietary Name:

Fludeoxyglucose F18

Non-Proprietary Name:

Fludeoxyglucose F18

Substance Name:

Fludeoxyglucose F-18

Usage Information:

Fludeoxyglucose F 18 Injection is a positron emitting radiopharmaceutical that is used for diagnostic purposes in conjunction with positron emission tomography (PET) imaging. The active ingredient 2-deoxy-2-[18F]fluoro-D-glucose has the molecular formula of C6H1118FO5 with a molecular weight of 181.26, and has the following chemical structure:

11-Digit NDC Billing Format:

60215041130

Product Type:

Human Prescription Drug

Labeler Name:

The University Of Texas Md Anderson Cancer Center

Dosage Form:

Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.

Administration Route(s):

Intravenous - Administration within or into a vein or veins.

Active Ingredient(s):

FLUDEOXYGLUCOSE F-18 300 mCi/mL

Pharmacologic Class(es):

Radioactive Diagnostic Agent - [EPC] (Established Pharmacologic Class)

Radiopharmaceutical Activity - [MoA] (Mechanism of Action)

Sample Package:

FDA Application Number:

ANDA203246

Marketing Category:

ANDA - A product marketed under an approved Abbreviated New Drug Application.

Start Marketing Date:

12-06-2011

Listing Expiration Date:

12-31-2024

Exclude Flag:

Code Structure:

60215 - The University Of Texas Md Anderson Cancer Center
- 60215-411 - Fludeoxyglucose
  - 60215-411-30 - 27 mL in 1 VIAL, GLASS

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package Code	Package Description
60215-411-15	15 mL in 1 VIAL, GLASS

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 60215-411-30?

The NDC Packaged Code 60215-411-30 is assigned to a package of 27 ml in 1 vial, glass of Fludeoxyglucose F18, a human prescription drug labeled by The University Of Texas Md Anderson Cancer Center. The product's dosage form is injection and is administered via intravenous form.

Is NDC 60215-411 included in the NDC Directory?

Yes, Fludeoxyglucose F18 with product code 60215-411 is active and included in the NDC Directory. The product was first marketed by The University Of Texas Md Anderson Cancer Center on December 06, 2011 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 60215-411-30?

The 11-digit format is 60215041130. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	60215-411-30	5-4-2	60215-0411-30

Table of Contents